Stroke
Conditions
Keywords
tACS, gamma synchrony
Brief summary
In the last decades, the research in neuroimaging-informed stroke prognosis and treatment has had a little clinical impact, often because of the costs of bringing complex procedures to the bedside. Cerebral stroke remains the leading cause of disability, with 65% of survivors chronically impaired at 6 months. Gamma synchrony (GS) is a fundamental mechanism of cortical function and can be estimated and modulated in a simple, inexpensive, and reliable way. It has provided valuable and cost-effective guidance in several neuropsychiatric conditions. In previous studies, we developed simple yet robust methods for assessing and manipulating GS and proved its relationship with clinical impairment in preliminary data. The aim of the present project is to predict and improve stroke recovery by leveraging cortical mapping and modulation of GS via transcranial alternating current stimulation (tACS), a safe and inexpensive technique. The project capitalizes on technology readily available to the Italian national health system.
Detailed description
The project will consist of 3 Work Packages (WPs): * The aim of WP1 is to map the relationship between GS and clinical outcomes with EEG. * The aim of WP2 is to translate GS assessment and modulation to bedside. * The aim of WP3 is to modulate GS to improve rehabilitation outcomes.
Interventions
The effect of transcranial alternating current stimulation (tACS) will be investigated in WP3. Patients will undergo standard intensive rehabilitation plus gamma tACS for two weeks.
In WP3, patients will undergo standard intensive rehabilitation plus sham tACS for two weeks.
Sponsors
Study design
Eligibility
Inclusion criteria
The participants in this study will be 140 stroke patients rehabilitated at IRCCS San Camillo hospital. 80 will participate in the WP1 and the WP2, while 60 will participate in the WP3 study. In WP1, data will also be collected on 80 healthy volunteer participants, approximately the same age as the patients. Inclusion Criteria (healthy participants) \- no neurological or psychiatric disorder Inclusion Criteria (patients) * right or left hemisphere damage * unilateral stroke * no comorbidities with psychiatric disorders
Exclusion criteria
(general): * Diagnosis of epilepsy or family history up to the second degree with it * Episodes of febrile convulsions or recurrent fainting * Head trauma * Presence of surgical clips or metal implants in the head * Diagnosis of heart disease * Presence of a cardiac pacemaker or artificial heart valve * Presence of hearing aids/prostheses * Hearing problems or tinnitus * Vision problems not corrected with lenses (such as color blindness) * Taking tricyclic antidepressant medications * Taking neuroleptic medications * Diagnosis of headache or migraine
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Gamma synchrony Work Package 1 (WP1) | baseline | Gamma synchrony will be measured via exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). Gamma synchrony will be quantified as power of the EEG gamma band. Gamma synchrony will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
| Gamma synchrony Work Package 3 (WP3) | baseline | Gamma synchrony will be measured via exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). Gamma synchrony will be quantified as power of the EEG gamma band. Gamma synchrony will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
| Gamma synchrony (reduced number of EEG sensors). Work Package 2 (WP2) | baseline | Gamma synchrony will be measured via exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). Gamma synchrony will be quantified as power of the EEG gamma band. Gamma synchrony will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Behavioral performance (response times). Work Package 1 (WP1) | baseline | Participants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of response times (how fast the participants complete the task). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
| Behavioral performance (accuracy). Work Package 3 (WP3) | baseline | Participants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of accuracy (% of correct responses). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
| Behavioral performance (response times). Work Package 3 (WP3) | baseline | Participants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of response times (how fast the participants complete the task). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
| Behavioral performance (accuracy). Work Package 1 (WP1) | baseline | Participants' cognitive performance at neuropsychological tests will be measured. Behavioral performance will be measured in terms of accuracy (% of correct responses). Behavioral performance will be measured at the baseline of the intervention (i.e., standard intensive rehabilitation at IRCCS S. Camillo Hospital) |
Countries
Italy